This transaction
This mergerCreating the future with AI 1. Store customer acquisition DX SaaS business 2. Real estate DX SaaS business 3. Web marketing business 4. Internet media business 5. Payment services business 6. AI- and SaaS-related businesses, including the above 7. Other internet customer acquisition businesses, SaaS business Internet media business Development business
The impact on results for the fiscal year ending December 2026 is expected to be minor. The outlook for results for the fiscal year ending December 2027 is scheduled to be disclosed when the Company announces its results for the fiscal year ending December 2026, scheduled for February 2027, taking the impact of the merger into account.
| Item | Details |
|---|---|
| Transaction name | This merger |
| Counterparty name | GMO TECH Co., Ltd., GMOデザインワン Co., Ltd. |
| Name of the Subject Company | GMO TECH Co., Ltd., GMOデザインワン Co., Ltd. |
| Business Description of the Subject Company | Creating the future with AI 1. Store customer acquisition DX SaaS business 2. Real estate DX SaaS business 3. Web marketing business 4. Internet media business 5. Payment services business 6. AI- and SaaS-related businesses, including the above 7. Other internet customer acquisition businesses, SaaS business Internet media business Development business |
| Location of the Subject Company | 26-1 Sakuragaoka-cho, Shibuya-ku, Tokyo, Shinjuku East Square Building, 2-16-6 Shinjuku, Shinjuku-ku, Tokyo |
| Capital Stock of the Subject Company | ¥100 million, ¥100 million |
| Date of Establishment of the Subject Company | 4 December 2006, 13 September 2005 |
| Type of Consideration | No consideration (no new shares or other assets will be issued or allocated) |
| Merger ratio/share exchange ratio | not disclosed (no issuance of new shares or allocation of other assets) |
| Voting rights ownership percentage | Before GMO TECH: 100%; GMOデザインワン: 100% (after not disclosed) |
| Impact on Business Performance | The impact on results for the fiscal year ending December 2026 is expected to be minor. The outlook for results for the fiscal year ending December 2027 is scheduled to be disclosed when the Company announces its results for the fiscal year ending December 2026, scheduled for February 2027, taking the impact of the merger into account. |
| Date of board resolution | 24 September 2026 |
| Contract Date | Mid-November 2026 (scheduled) |
| Execution Date / Effective Date | 1 January 2027 (scheduled) |
| Management structure after acquisition | The corporate name will be GMO TECH Co., Ltd. The registered office will be 26-1 Sakuragaoka-cho, Shibuya-ku, Tokyo. The planned representative director and president is Osawa Kento (大澤 健人), the planned chairperson of the board is Suzuki Akito (鈴木明人), the planned deputy president and director is Suzuki Ryoichi (鈴木亮一), and the planned corporate auditor is Tanaka Makoto (田中誠). On the effective date, Osawa Kento (大澤健人) will become representative director and president, and Suzuki Ryoichi (鈴木亮一) is scheduled to become deputy president and director without representative authority. Employee treatment: not disclosed |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company will further advance the business collaboration and the integration of regulations, systems and information systems undertaken since the management integration in October 2025, and will make the two companies a single organisation to accelerate decision-making and improve management efficiency. The Company explains that this will enhance the competitiveness of the consolidated corporate group and contribute to achieving the targets of its medium-term management plan.